• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用阵列比较基因组杂交技术对侵袭性黑色素瘤细胞系进行基因组分析。

Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.

作者信息

Koroknai Viktória, Ecsedi Szilvia, Vízkeleti Laura, Kiss Tímea, Szász István, Lukács Andrea, Papp Orsolya, Ádány Róza, Balázs Margit

机构信息

aDepartment of Preventive Medicine, Faculty of Public Health bMTA-DE Public Health Research Group, University of Debrecen, Debrecen, Hungary.

出版信息

Melanoma Res. 2016 Apr;26(2):100-7. doi: 10.1097/CMR.0000000000000227.

DOI:10.1097/CMR.0000000000000227
PMID:26656572
Abstract

Malignant melanoma is one of the most aggressive human cancers. Invasion of cells is the first step in metastasis, resulting in cell migration through tissue compartments. We aimed to evaluate genomic alterations specifically associated with the invasive characteristics of melanoma cells. Matrigel invasion assays were used to determine the invasive properties of cell lines that originated from primary melanomas. Array comparative genomic hybridization analyses were carried out to define the chromosome copy number alterations (CNAs). Several recurrent CNAs were identified by array comparative genomic hybridization that affected melanoma-related genes. Invasive primary cell lines showed high frequencies of CNAs, including the loss of 7q and gain of 12q chromosomal regions targeting PTPN12, ADAM22, FZD1, TFPI2, GNG11, COL1A2, SMURF1, VGF, RELN and GLIPR1 genes. Gain of the GDNF (5p13.1), GPAA1, PLEC and SHARPIN (8q24.3) genes was significantly more frequent in invasive cell lines compared with the noninvasive ones. Importantly, copy number gains of these genes were also found in cell lines that originated from metastases, suggesting their role in melanoma metastasis formation. The present study describes genomic differences between invasive and noninvasive melanoma cell lines that may contribute toward the aggressive phenotype of human melanoma cells.

摘要

恶性黑色素瘤是最具侵袭性的人类癌症之一。细胞侵袭是转移的第一步,导致细胞通过组织间隙迁移。我们旨在评估与黑色素瘤细胞侵袭特性特异性相关的基因组改变。使用基质胶侵袭试验来确定源自原发性黑色素瘤的细胞系的侵袭特性。进行了阵列比较基因组杂交分析以确定染色体拷贝数改变(CNA)。通过阵列比较基因组杂交鉴定了几种影响黑色素瘤相关基因的复发性CNA。侵袭性原代细胞系显示出高频率的CNA,包括7号染色体长臂缺失和12号染色体长臂增加,靶向PTPN12、ADAM22、FZD1、TFPI2、GNG11、COL1A2、SMURF1、VGF、RELN和GLIPR1基因。与非侵袭性细胞系相比,侵袭性细胞系中GDNF(5p13.1)、GPAA1、PLEC和SHARPIN(8q24.3)基因的增加明显更频繁。重要的是,在源自转移灶的细胞系中也发现了这些基因的拷贝数增加,表明它们在黑色素瘤转移形成中的作用。本研究描述了侵袭性和非侵袭性黑色素瘤细胞系之间的基因组差异,这些差异可能导致人类黑色素瘤细胞的侵袭性表型。

相似文献

1
Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.采用阵列比较基因组杂交技术对侵袭性黑色素瘤细胞系进行基因组分析。
Melanoma Res. 2016 Apr;26(2):100-7. doi: 10.1097/CMR.0000000000000227.
2
Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.通过 array 比较基因组杂交揭示 BRAF 和 NRAS 突变原发性黑色素瘤之间明显的遗传差异。
Melanoma Res. 2012 Jun;22(3):202-14. doi: 10.1097/CMR.0b013e328352dbc8.
3
Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor.微阵列比较基因组杂交检测促纤维增生性黑色素瘤和恶性外周神经鞘膜瘤中的拷贝数变化。
Am J Dermatopathol. 2011 Dec;33(8):780-5. doi: 10.1097/DAD.0b013e31820dfcbf.
4
Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.黑色素瘤基因组中的体细胞改变:基于高分辨率阵列的比较基因组杂交研究。
Genes Chromosomes Cancer. 2010 Aug;49(8):733-45. doi: 10.1002/gcc.20785.
5
Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.使用平铺分辨率阵列比较基因组杂交技术对恶性黑色素瘤进行基因组分析。
Oncogene. 2007 Jul 12;26(32):4738-48. doi: 10.1038/sj.onc.1210252. Epub 2007 Jan 29.
6
[Genomic alterations of invasive melanoma cells].[侵袭性黑色素瘤细胞的基因组改变]
Magy Onkol. 2022 Oct 5;66(3):243-245. Epub 2022 Aug 22.
7
Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization.基于阵列比较基因组杂交的黏膜下浸润性胃癌的基因组分析。
PLoS One. 2011;6(7):e22313. doi: 10.1371/journal.pone.0022313. Epub 2011 Jul 21.
8
Monoallelic expression in melanoma.黑色素瘤中的单等位基因表达。
J Transl Med. 2019 Apr 5;17(1):112. doi: 10.1186/s12967-019-1863-x.
9
Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome.通过激光捕获或手动显微切割的中期比较基因组杂交检测原发性皮肤黑色素瘤中的基因组改变:6p增益可能预示预后不良。
Cancer Genet Cytogenet. 2005 Feb;157(1):1-11. doi: 10.1016/j.cancergencyto.2004.06.004.
10
Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.皮肤恶性黑色素瘤患者的多个转移灶可能表现出异质性的基因组和表观基因组模式。
Melanoma Res. 2010 Oct;20(5):381-91.

引用本文的文献

1
Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines.黑色素瘤细胞系中恩考芬尼和比美替尼联合治疗期间与获得性耐药相关的分子改变
Cancers (Basel). 2021 Dec 1;13(23):6058. doi: 10.3390/cancers13236058.
2
Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.沉默骨桥蛋白表达抑制黑色素瘤细胞增殖、侵袭并诱导蛋白表达改变。
Pathol Oncol Res. 2021 Mar 5;27:581395. doi: 10.3389/pore.2021.581395. eCollection 2021.
3
SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer's Disease?
SHARPIN:在阿尔茨海默病中寻找 NEMO 和在淀粉样β清除和降解(ABCD)途径中的作用?
Cell Mol Neurobiol. 2022 Jul;42(5):1267-1281. doi: 10.1007/s10571-020-01023-w. Epub 2021 Jan 5.
4
Progress in the correlation between PTPN12 gene expression and human tumors.蛋白酪氨酸磷酸酶非受体型12(PTPN12)基因表达与人类肿瘤相关性的研究进展
Medicine (Baltimore). 2020 Jun 12;99(24):e20445. doi: 10.1097/MD.0000000000020445.
5
Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma.在一种新的血管肉瘤小鼠模型中,联合抑制mTOR和MEK是一种有效的治疗方法。
Oncotarget. 2018 May 15;9(37):24750-24765. doi: 10.18632/oncotarget.25345.